医学
来复枪
急性肾损伤
肌酐
肾脏替代疗法
多器官功能障碍综合征
血尿素氮
内科学
沙发评分
死亡率
器官功能障碍
平均动脉压
损伤严重程度评分
血压
血液滤过
外科
病危
败血症
血液透析
心率
毒物控制
急诊医学
伤害预防
考古
历史
出处
期刊:Chinese Journal of Blood Purification
日期:2007-01-01
摘要
Objective To investigate the prognosis of patients with multiple organ dysfunction syn- drome (MODS) using continuous renal replacement therapy for the treatment of their acute kidney injury (AKI) in different severity. Methods We retrospective studied 240 patients with MODS treated with continu- ous veno-venous hemofiltration (CVVH) in the period of Jan. 2004 to Dec. 2006. The severity of AKI in these patients was classified as AKI of phase I, II and III according to the RIFLE criteria. The mortality rate in hospital and the number of failed organs were compared among patients with different severity of AKI. Their APACHE II score, sequential organ failure assessment (SOFA) score, mean arterial pressure, oxygenate index, blood urea nitrogen and serum creatinine were also compared before and after CVVH for 24 hours. Results ① The overall mortality rate in hospital was 38.75%. The rate was higher in patients with AKI of phase III than those with phase I and II (P 0.05). ② The number of failed organs was higher in patients with severe AKI. Patients with more failed organs had significantly higher mortality rate in hospital. Patients presenting ≥ 4 failed organs had higher mortality rate in hospital than those showing ≤ 3 failed organs (75.5% vs 13.4%, P 0.05). ③ After CVVH for 24 hours, mean arterial pressure, oxygenate index, blood urea nitrogen and serum creatinine improved significantly in all patients. APACHE II score and SOFA score decreased significantly in patients with AKI of phase I and II, but insignificantly in those with AKI of phase III. Conclusions CVVH is an effective measure for MODS patients complicated with severe acute renal failure. RIFLE criteria is useful for the early diagnosis and prognosis prediction of AKI. CVVH remarkably improves the prognosis of MODS with AKI of phase I or II.
科研通智能强力驱动
Strongly Powered by AbleSci AI